RU93054526A - Quinazoline derivatives, method for their preparation, use - Google Patents
Quinazoline derivatives, method for their preparation, useInfo
- Publication number
- RU93054526A RU93054526A RU93054526/04A RU93054526A RU93054526A RU 93054526 A RU93054526 A RU 93054526A RU 93054526/04 A RU93054526/04 A RU 93054526/04A RU 93054526 A RU93054526 A RU 93054526A RU 93054526 A RU93054526 A RU 93054526A
- Authority
- RU
- Russia
- Prior art keywords
- group
- fragment
- alkyl
- amino
- alkoxy
- Prior art date
Links
- 125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 title claims 2
- 125000003277 amino group Chemical group 0.000 claims 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000004429 atoms Chemical group 0.000 claims 1
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000005842 heteroatoms Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- -1 hydroxylamino group Chemical group 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 102000027656 receptor tyrosine kinases Human genes 0.000 claims 1
- 108091007921 receptor tyrosine kinases Proteins 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
Claims (1)
где m = 1, 2 или 3, а каждый радикал R1 независимо является гидроксильной группой, аминогруппой, уреидогруппой, гидроксиламиногруппой, трифторметоксигруппой, C1 - C4-алкильной группой, C1 - C4-алкоксигруппой, C1 - C3- алкилендиоксигруппой, а Q является 9- или 10-членным бициклическим гетероциклическим фрагментом, содержащим один или два азотных гетероатома и дополнительно имеющим еще один гетероатом, выбранный из атома азота, кислорода, серы, или же Q является 9- или 10-членным бициклическим арильным фрагментом, при этом гетероциклический или арильный фрагмент может дополнительно содержать один или два заместителя, выбранных из атома галогена, оксигруппы, оксогруппы, аминогруппы, нитрогруппы, карбамоильной группы, С1 - C4- алкильной группы, C1 - C4-алкоксигруппы, C1 - C4-алкиламиногруппы, ди-[(C1 - C4-алкил]аминогруппы, и C2 - C4-алканоиламиногруппы; или их фармацевтически приемлемая соль; способ их получения, фармацевтический состав, содержащий их, и использование ингибирующих свойств соединений по отношению к рецепторной тирозинкиназе при лечении рака.The invention relates to quinazoline derivatives of the general formula
where m = 1, 2, or 3 and each radical R 1 independently is a hydroxyl group, amino group, ureido group, a hydroxylamino group, trifluoromethoxy group, C 1 - C 4 alkyl group, C 1 - C 4 alkoxy, C 1 - C 3 - alkylenedioxy group, and Q is a 9- or 10-membered bicyclic heterocyclic fragment containing one or two nitrogen heteroatoms and additionally having another heteroatom selected from an atom of nitrogen, oxygen, sulfur, or Q is a 9- or 10-membered bicyclic aryl fragment while heterocyclic or aryl the fragment may further contain one or two substituents selected from a halogen atom, an oxy group, an oxo group, an amino group, a nitro group, a carbamoyl group, a C 1 - C 4 alkyl group, a C 1 - C 4 alkoxy group, a C 1 - C 4 alkylamino group, di - [(C 1 -C 4 -alkyl] amino groups, and C 2 -C 4 -alkanoylamino groups; or a pharmaceutically acceptable salt thereof; method for their preparation, pharmaceutical composition containing them, and use of the inhibitory properties of compounds with respect to receptor tyrosine kinase in cancer treatment.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9225765.8 | 1992-12-10 | ||
GB9310248.1 | 1993-05-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU93054526A true RU93054526A (en) | 1996-12-27 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2103383A1 (en) | Quinazoline derivatives | |
RU2221798C2 (en) | Imidazonaphthyridines, pharmaceutical composition based on thereof, method for stimulating biosynthesis of cytokine and intermediate compounds | |
RU2004130488A (en) | Pyrimidine derivatives | |
RU93004423A (en) | HINAZOLINE DERIVATIVE, METHOD FOR ITS OBTAINING, PHARMACEUTICAL COMPOSITION ON ITS BASIS AND APPLICATION | |
HUP0203425A2 (en) | Quinazoline derivatives, process for their preparation and their use | |
CA2015996A1 (en) | Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals | |
RU94019334A (en) | Inhibitors of steroid sulfatase | |
RU2000127751A (en) | ANTI-TUMOR MEDICINE | |
DE69427104D1 (en) | Quinazoline derivatives and their use as cancer drugs | |
CA2455181A1 (en) | Benzimidazo[4,5-f]isoquinolinone derivatives | |
DE69033915D1 (en) | Xanthine derivatives, processes for their preparation and their pharmaceutical use | |
KR890013035A (en) | Indolocarbazole derivatives, preparation method thereof and pharmaceutical composition containing them | |
KR890014479A (en) | Arylhydrazone | |
RU93054537A (en) | DERIVATIVES OF GUANIDINALKYL-1,1-BISPHOSPHONIC ACID, METHOD FOR PRODUCING AND USING THEM | |
RU93004675A (en) | 1,2,4-Oxadiazolyl-phenoxyalkylisoxazoles, their use as antiviral agents, pharmaceutical composition | |
RU93004926A (en) | Quinoline and Quinazoline Derivatives, Method for Their Preparation and Pharmaceutical Composition | |
ATE70839T1 (en) | INDOLOCARBAZOLE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS. | |
ES2045420T3 (en) | CYCLIC AMIDES. | |
NZ228722A (en) | Substituted indole and indazole derivatives and pharmaceutical compositions | |
RU94039545A (en) | New adenosine derivatives, methods of their synthesis, pharmaceutical compositions based on thereof, methods of preparing pharmaceutical compositions and their use | |
RU93054526A (en) | Quinazoline derivatives, method for their preparation, use | |
RU97107018A (en) | QUINOXALINE DERIVATIVES USED IN THERAPY | |
IL83088A (en) | Substituted 3-isoquinolinols,their preparation and pharmaceutical compositions containing them | |
RU99100107A (en) | DERIVATIVES OF DIBENZOOXAZEPINE AND DIBENZODIOXEPINE AND THEIR APPLICATION AS ANTI-TUMOR AGENTS | |
RU92016209A (en) | Benzofuranylimidazole derivatives, method for their production and therapeutic compositions containing derivatives |